title: Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic mice.
abstract: OBJECTIVE
  We recently described that hypertriglyceridemic apolipoprotein (apo) CIII transgenic mice show increased whole body metabolic rate. In this study, we used these apo CIII-expressing mice, combined or not with the expression of the natural promoter-driven CETP gene, to test the hypothesis that both proteins modulate diet-induced obesity.
  
  
  RESULTS
  Mice expressing apo CIII, CIII/CETP, CETP and nontransgenic (NonTg) mice were maintained on a high-fat diet (14% fat by weight) during 20 weeks after weaning. At the end of this period, all groups exhibited the expected lipemic phenotype. Fasting glucose levels were neither affected by the high-fat diet nor by the distinct genotypes. However, apo CIII mice showed significantly higher glycemia ( approximately 35%) and lower insulin levels ( approximately 45%) in the fed state, compared with the NonTg mice. The apo CIII mice presented significantly increased body weight, lipid content of the carcass ( approximately 25%), visceral adipose tissue mass (about twofold) and adipocyte size ( approximately 25%) compared with the CETP and NonTg mice. The CETP expression in the apo CIII background normalized the subcutaneous adipose depot and visceral adipocyte size to the levels of NonTg mice. Plasma leptin levels were lower in CETP groups (25-50%) and higher in the apo CIII mice. Similar core body temperature in all groups and similar liver mitochondrial resting respiration rates in CIII and NonTg mice indicate no differences in basal energy expenditure rates among these mice fed a high-fat diet.
  
  
  CONCLUSIONS
  The elevation of plasma apo CIII levels aggravates diet-induced obesity and the expression of physiological levels of circulating CETP reverses this adipogenic effect, indicating a novel role for CETP in modulating adiposity.
authors.affiliation: Departamento de Fisiologia e Biofísica, Instituto de Biologia, Universidade Estadual de Campinas, 13086-970 Campinas, SP, Brazil.
authors.forename: A G
authors.initials: AG
authors.lastname: Salerno
authors.forename: T R
authors.initials: TR
authors.lastname: Silva
authors.forename: M E C
authors.initials: ME
authors.lastname: Amaral
authors.forename: L C
authors.initials: LC
authors.lastname: Alberici
authors.forename: M L
authors.initials: ML
authors.lastname: Bonfleur
authors.forename: P R
authors.initials: PR
authors.lastname: Patrício
authors.forename: E P M S
authors.initials: EP
authors.lastname: Francesconi
authors.forename: D M
authors.initials: DM
authors.lastname: Grassi-Kassisse
authors.forename: A E
authors.initials: AE
authors.lastname: Vercesi
authors.forename: A C
authors.initials: AC
authors.lastname: Boschero
authors.forename: H C F
authors.initials: HC
authors.lastname: Oliveira
mesh_terms: D000818:Animals; D053305:Apolipoprotein C-III / Q000502:physiology*; D001823:Body Composition / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D053480:Cholesterol Ester Transfer Proteins / Q000502:physiology*; D005215:Fasting / Q000097:blood / Q000378:metabolism*; D015228:Hypertriglyceridemia / Q000097:blood / Q000378:metabolism*; D020738:Leptin / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009765:Obesity
chemical_list: D053305:Apolipoprotein C-III; D053480:Cholesterol Ester Transfer Proteins; D020738:Leptin